';
CLOSE
Policy Areas

0 435

The Office of Child Development & Early Learning (OCDEL) notified all County Early Intervention (EI) Programs and Providers that they will perform one final Mass Claims Adjustment on April 21, 2026.

As a result of the final analysis of the denied claims file, they were able to identify that many of the denied claims can be processed again and should result in a Paid claim. This final Mass Claims Adjustment will significantly reduce the manual efforts for both the County and EI Provider.

Immediately following this final Mass Claims Adjustment, a revised and final report of denied claims will be issued to all County EI programs to distribute to their contracted providers. 

Reminder of Next Steps:

  • Using the newly published Fiscal Year 2025/26 Fee Schedule — File NEW claims on or after March 9, 2026, that contain a date of service on or after July 1, 2025.
  • Using the newly published Fiscal Year 2025/26 Fee Schedule — Adjust claims filed on or after March 9, 2026, that contain a date of service on or after July 1, 2025, if the OLD fee schedule was used.

The Bureau thanks all stakeholders for their patience as they work to streamline the process and expedite the payments for provided Early Intervention services.

0 446

The Office of Developmental Programs (ODP) has shared ODPANN 26-043, which states that the Temple University Harrisburg Certified Investigator Program will be facilitating the June Forum for Certified Investigators (CI) and others involved in the incident investigation process.

During this forum, ODP and the CI Program staff will explain the new quality review tool and share standards and trends identified during the current quality review process.

Date and Time:
Friday, June 12, 2026
10:00 am – 11:30 am
Topic: “Raising the Standard: The Temple – ODP Investigation Quality Review Process in Depth”
Register Here: CI Forum

Please complete a short survey and submit your topic-related questions before the close of business on Friday, June 5.

View the announcement for more information and details.

0 484

The Department of Drug and Alcohol Programs (DDAP) Training Section is gathering input from professionals in the substance use disorder and problem gambling fields who serve in supervisory, management, and executive roles. Your feedback will help DDAP better understand workforce training needs, preferences, and barriers and inform future training opportunities.

If you previously completed this survey when it was shared last month, there is no need to complete it again.

The deadline to complete the survey is Friday, May 1.

0 449

Due to a widespread technical outage, IPRC will need to reschedule the “Family-Centered Care” webinar that was scheduled for today, April 20, at 11:00 am. The new date and time will be Monday, April 27, at 1:00 pm. If you have already registered, you do not need to re-register.

We apologize for the inconvenience. Please contact Cindi Hobbes if you have any questions.

0 547
MEDICAID text on a keyboard with stethoscope , medical concept

The Office of Developmental Programs (ODP) has shared a reminder of the importance of supporting individuals in maintaining their eligibility for Medicaid and in verifying an individual’s eligibility for Medicaid prior to delivering services.

Each month, the Office of Developmental Programs (ODP) generates an “MA Reapplications Due Soon” report for each Administrative Entity (AE) and Supports Coordination Organization (SCO). The report is uploaded to the internet version of DocuShare and can be found using the following path:

AEs: ODP –> Division of Program Analysis –> Select Region Folder –> Select County/Joinder Folder –> County Dashboards

Intellectual Disability/Autism (ID/A) SCOs: ODP –> Division of Program Analysis –> ID/A Supports Coordination Organization –> Select Region Folder –> Select the ID/A SCO

Adult Autism Waiver (AAW) SCOs: ODP’s Bureau of Supports for Autism and Special Populations (BSASP) sends each SCO a monthly report of impacted individuals they serve for follow-up. Please note that AAW SCOs who are serving individuals whose MA is not coming due within the next four months will not receive a monthly report.

Please view ODPANN 25-097 for additional details and information.

Attachments:

0 862

The Office of Developmental Programs (ODP) shared this important announcement from the U. S. Food and Drug Administration (FDA). The FDA is aware that Philips has issued a letter to affected customers recommending all Trilogy ventilators be corrected prior to continued use. This includes Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal devices.

Philips has identified three issues affecting Trilogy Evo Platform ventilators:

  • Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
  • Aerosol buildup on the internal flow sensor may interfere with the sensor’s ability to accurately measure airflow, leading to incorrect flow calculations and potentially impacting the therapy delivered to the patient.
  • In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards – two breath cycles, or five seconds. In certain ventilation modes, with or without backup rates, the alarm could be delayed by up to four breaths.

This recall involves correcting devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction. View the full list of affected products here.

What to Do:

Update all Trilogy Evo Platform ventilators with software version 1.05.15.00. Stop all use of non-pneumatic nebulizers with all Trilogy Evo Platform ventilators. Review the latest User Manual Addendum.

On March 2, Philips sent all affected customers a letter recommending the following actions:

  • Update all Trilogy Evo Platform ventilators with software version 1.05.15.00. The software is available as free download through the My Philips for Professionals (MyP4P) and InCenter websites.
  • Review the latest version of the User Manual Addendum. Ensure a copy of all product literature, including the User Manual Addendum, is included with every Trilogy Evo Platform ventilator in your fleet.
  • Stop all use of non-pneumatic nebulizers, including vibrating mesh nebulizers, with all Trilogy Evo Platform ventilators.
  • Communicate this notice to anyone in your organization who interacts with a Trilogy Evo Platform ventilator, including clinicians, therapists, nurses, caregivers, and patients. Ensure they are aware of the changes regarding the use of nebulizers with these ventilators and that non-pneumatic nebulizers are not to be used.
  • If a Trilogy Evo Platform ventilator previously in your possession has been transferred, ensure this information is communicated to them, including the User Manual Addendum.

Visit the FDA’s website for additional information and next steps.

0 878
physiotherapist helping patient to walk

The Centers for Medicare and Medicaid Services (CMS) recently released the fiscal year (FY) 2027 hospital inpatient prospective payment system (IPPS) proposed rule. Included in this rule is a proposal for the expansion of CMS’s Comprehensive Care for Joint Replacement (CCJR) model nationwide to improve care coordination and reduce costs for Medicare patients undergoing hip, knee, and ankle replacements. The model would hold hospitals accountable for the full episode of care, including surgery and 90 days of recovery, encouraging better outcomes and a more efficient use of resources.

For background purposes, from April 2016 through December 2024, the CMS Innovation Center tested the CJR Model to improve care for Medicare patients undergoing joint replacement procedures. During that time, the model generated significant Medicare savings while maintaining quality of care for beneficiaries. Under the CJR Model, hospitals were held responsible for Medicare spending for the joint replacement surgery, the hospital stay, and the first 90 days of recovery, including follow-up care such as physical therapy.

Based on the evaluation of the CJR Model, the CJR Expanded (CJR-X) Model would create strong incentives for hospitals to coordinate care more effectively, avoid unnecessary services like avoidable re-hospitalization and emergency care, and focus on delivering the best outcomes for patients. It would specifically encourage better communication with post-acute care providers to support recovery. Beginning October 1, 2027, CJR-X would be required for most hospitals, making it the first mandatory, nationwide test of an episode-based payment model.

Comments on the proposed rule are due by June 9, 2026.

Prev1...678...514Next Page 7 of 514
© 2021 - Rehabilitation & Community Providers Association